(Q38848213)

7 September 2017

1 reference

title

Biological Response Modifier in Cancer Immunotherapy (English)

1 reference

7 September 2017

1 reference

Ronghua Liu

1

1 reference

7 September 2017

Feifei Luo

2

1 reference

7 September 2017

Xiaoming Liu

3

1 reference

7 September 2017

Luman Wang

4

1 reference

7 September 2017

Jiao Yang

5

1 reference

7 September 2017

Yuting Deng

6

1 reference

7 September 2017

Enyu Huang

7

1 reference

7 September 2017

Jiawen Qian

8

1 reference

7 September 2017

Zhou Lu

9

1 reference

7 September 2017

Xuechao Jiang

10

1 reference

7 September 2017

Dan Zhang

11

1 reference

7 September 2017

Yiwei Chu

12

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 January 2016

1 reference

Advances in Experimental Medicine and Biology

7 September 2017

1 reference

7 September 2017

909

1 reference

7 September 2017

69-138

1 reference

Toll-like receptor agonists in cancer therapy

7 September 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Cross-regulation between cytokine and microRNA pathways in T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Macrophage cytokines: involvement in immunity and infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Cytokine treatment in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Developing therapeutic microRNAs for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Th17 cells in cancer: the ultimate identity crisis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Polycation-based nanoparticles for RNAi-mediated cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Roles of toll-like receptors in cancer: a double-edged sword for defense and offense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Antisense intergenic transcription in V(D)J recombination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Cell-mediated autophagy promotes cancer cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Modulating T-cell homeostasis with IL-7: preclinical and clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

A long noncoding RNA mediates both activation and repression of immune response genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MicroRNA-125b potentiates macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Twelve immunotherapy drugs that could cure cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

TLR9 ligand enhances proliferation of rat CD4+ T cell and modulates suppressive activity mediated by CD4+ CD25+ T cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Particle-mediated delivery of cytokines for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Successful Treatment of Giant Basal Cell Carcinoma with Topical Imiquimod 5% Cream with Long Term Follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Next-generation sequencing of microRNAs uncovers expression signatures in polarized macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Immunotherapeutic applications of IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

IL-21: a pleiotropic cytokine with potential applications in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

HMGB1 mediates endogenous TLR2 activation and brain tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Limited miR-17-92 overexpression drives hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The interferon system: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Interleukin-2 is essential for CD4+CD25+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

New core-shell nanoparticules for the intravenous delivery of siRNA to experimental thyroid papillary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MicroRNAs and dendritic cell-based vaccination in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Noncoding RNA in oncogenesis: a new era of identifying key players

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Combination of interleukin-12 gene therapy, metronomic cyclophosphamide and DNA cancer vaccination directs all arms of the immune system towards tumor eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Autocrine IL-8 and VEGF mediate epithelial-mesenchymal transition and invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Late-Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Complex roles of inflammasomes in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Efficient inhibition of miR-155 function in vivo by peptide nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The role of the mediators of inflammation in cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Long noncoding RNAs in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Toll-like receptor ligands directly promote activated CD4+ T cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

When Toll-like receptor and T-cell receptor signals collide: a mechanism for enhanced CD8 T-cell effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-γ locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

TLR ligands in the local treatment of established intracerebral murine gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The hallmarks of cancer: a long non-coding RNA point of view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Circular RNA and miR-7 in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Cancer, inflammation, and therapy: effects on cytochrome p450-mediated drug metabolism and implications for novel immunotherapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The blood-brain barrier/neurovascular unit in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

TLR3 ligand stimulates fully functional memory CD8+ T cells in the absence of CD4+ T-cell help.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Long non-coding RNAs in the regulation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Toll-like receptors on tumor cells facilitate evasion of immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

miRNA-15a/16: as tumor suppressors and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Large non-coding RNAs: missing links in cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Prostate cancer gene expression marker 1 (PCGEM1): a patented prostate- specific non-coding gene and regulator of prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Treatment of HCV infection by targeting microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Structures of the toll-like receptor family and its ligand complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Expression and function of Toll-like receptors in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Structural biology of the Toll-like receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MicroRNA-205 directly regulates the tumor suppressor, interleukin-24, in human KB oral cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Dynamic microRNA gene transcription and processing during T cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Design of antisense oligonucleotides stabilized by locked nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Innate immunity in the CNS: redefining the relationship between the CNS and Its environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Interleukin 12: still a promising candidate for tumor immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Cytokines in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5' UTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MicroRNA-155 and MicroRNA-21 promote the expansion of functional myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

microRNAs and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Structural and functional features of central nervous system lymphatic vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Regulatory T cells in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Toxicity of cationic lipids and cationic polymers in gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Promotion of embryonic cortico-cerebral neuronogenesis by miR-124.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Activated human neonatal CD8+ T cells are subject to immunomodulation by direct TLR2 or TLR5 stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Resiquimod, a topical drug for viral skin lesions and skin cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Topical pharmacotherapy for skin cancer: part II. Clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Mechanisms of Cisplatin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Multiple tumor-associated microRNAs modulate the survival and longevity of dendritic cells by targeting YWHAZ and Bcl2 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Mir-34: a new weapon against cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

A balance of interleukin-12 and -23 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

A phase I dose-finding study of the novel Toll-like receptor 8 agonist VTX-2337 in adult subjects with advanced solid tumors or lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MicroRNAs in immune regulation--opportunities for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Immune surveillance in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Role of microRNAs and long-non-coding RNAs in CD4(+) T-cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Genome-Wide Identification of Long Noncoding RNAs in CD8+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Interleukin-6 mediated upregulation of CYP1B1 and CYP2E1 in colorectal cancer involves DNA methylation, miR27b and STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Non-coding RNAs as direct and indirect modulators of epigenetic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Single-agent interleukin-2 in the treatment of metastatic melanoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Evolution and functions of long noncoding RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Current concepts and management of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The contribution of direct TLR signaling to T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Role of microRNAs in the immune system, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

CpG-ODNs induces up-regulated expression of chemokine CCL9 in mouse macrophages and microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The first 1000 dendritic cell vaccinees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Induction of IL-4Rα-dependent microRNAs identifies PI3K/Akt signaling as essential for IL-4-driven murine macrophage proliferation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Toll-like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Interleukin and interleukin receptor diversity: role of alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Regulatory T cells: key controllers of immunologic self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

TLR3 can directly trigger apoptosis in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The regulation of IL-10 production by immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Randomized, single-blind, placebo-controlled study of topical application of the immune response modulator resiquimod in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Achieving successful delivery of oligonucleotides--From physico-chemical characterization to in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MAP1S controls breast cancer cell TLR5 signaling pathway and promotes TLR5 signaling-based tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Altered macrophage differentiation and immune dysfunction in tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The nature of the principal type 1 interferon-producing cells in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The IL-2 cytokine family in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

A review of immunomodulators with reference to Canova.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Cytokines in cancer immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Sensing of microbial molecular patterns by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Macrophage regulation of tumor angiogenesis: implications for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

miR-511-3p modulates genetic programs of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MicroRNA-mediated control of macrophages and its implications for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Clinical significance of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Toll-like receptor 2 controls expansion and function of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Targeting of IL-4 and IL-13 receptors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

A phase II dose-ranging study of topical resiquimod to treat actinic keratosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Safety and efficacy of PF-3512676 for the treatment of stage IV renal cell carcinoma: an open-label, multicenter phase I/II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The role of GM-CSF in enhancing immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Resiquimod and other immune response modifiers as vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Prior TLR5 induction in human T cells results in a transient potentiation of subsequent TCR-induced cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Trial Watch: Toll-like receptor agonists for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

The role IL-1 in tumor-mediated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Endotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

A strategy for probing the function of noncoding RNAs finds a repressor of NFAT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

miR-21 targets Fas ligand-mediated apoptosis in breast cancer cell line MCF-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Topical imiquimod has therapeutic and immunomodulatory effects against intracranial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Interleukins in glioblastoma pathophysiology: implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

MiRNAs and LincRNAs: Could they be considered as biomarkers in colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Interleukin-7 and interleukin-15 for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Progress in microRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Systemic injection of TLR1/2 agonist improves adoptive antigen-specific T cell therapy in glioma-bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Interleukin-15 gene therapy and the mammalian target of rapamycin inhibitor everolimus inhibit the growth of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel anti-inflammation mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Dynamically expressed microRNA-15b modulates the activities of CD8+ T lymphocytes in mice with Lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Non-coding RNAs and their epigenetic regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

TLR2 engagement on CD8 T cells lowers the thresholdfor optimal antigen-induced T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-94-017-7555-7_2

10.1007/978-94-017-7555-7_2

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference